Literature DB >> 18463683

Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type.

Saunie M Hutton1, Richard A Spritz.   

Abstract

Oculocutaneous albinism (OCA) is a genetically heterogeneous group of disorders characterized by absent or reduced pigmentation of the skin, hair, and eyes. In humans, four genes have been associated with "classical" OCA and another 12 genes with syndromic forms of OCA. To assess the prevalence of different forms of OCA and different gene mutations among non-Hispanic Caucasian patients, we performed DNA sequence analysis of the four genes associated with "classical" OCA (TYR, OCA2, TYRP1, SLC45A2), the two principal genes associated with syndromic OCA (HPS1, HPS4), and a candidate OCA gene (SILV), in 121 unrelated, unselected non-Hispanic/Latino Caucasian patients carrying the clinical diagnosis of OCA. We identified apparent pathologic TYR gene mutations in 69% of patients, OCA2 mutations in 18%, SLC45A2 mutations in 6%, and no apparent pathological mutations in 7% of patients. We found no mutations of TYRP1, HPS1, HPS4, or SILV in any patients. Although we observed a diversity of mutations for each gene, a relatively small number of different mutant alleles account for a majority of the total. This study demonstrates that, contrary to long-held clinical lore, OCA1, not OCA2, is by far the most frequent cause of OCA among Caucasian patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463683      PMCID: PMC3515683          DOI: 10.1038/jid.2008.109

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  19 in total

1.  P gene mutations in patients with oculocutaneous albinism and findings suggestive of Hermansky-Pudlak syndrome.

Authors:  N A Garrison; Z Yi; O Cohen-Barak; M Huizing; L M Hartnell; W A Gahl; M H Brilliant
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

2.  Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment.

Authors:  L B Giebel; K M Strunk; R A Spritz
Journal:  Genomics       Date:  1991-03       Impact factor: 5.736

3.  Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan.

Authors:  Y Tomita; Y Miyamura; M Kono; R Nakamura; J Matsunaga
Journal:  Pigment Cell Res       Date:  2000

4.  Six novel P gene mutations and oculocutaneous albinism type 2 frequency in Japanese albino patients.

Authors:  Tamio Suzuki; Yoshinori Miyamura; Jun Matsunaga; Hiroshi Shimizu; Yasuhiro Kawachi; Naoko Ohyama; Osamu Ishikawa; Tomoyuki Ishikawa; Hiroshi Terao; Yasushi Tomita
Journal:  J Invest Dermatol       Date:  2003-05       Impact factor: 8.551

5.  Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene.

Authors:  Tamio Suzuki; Wei Li; Qing Zhang; Amna Karim; Edward K Novak; Elena V Sviderskaya; Simon P Hill; Dorothy C Bennett; Alex V Levin; H Karel Nieuwenhuis; Chin-To Fong; Claudio Castellan; Bianca Miterski; Richard T Swank; Richard A Spritz
Journal:  Nat Genet       Date:  2002-02-11       Impact factor: 38.330

6.  Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.

Authors:  R Gershoni-Baruch; A Rosenmann; S Droetto; S Holmes; R K Tripathi; R A Spritz
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

7.  Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan.

Authors:  Katsuhiko Inagaki; Tamio Suzuki; Hiroshi Shimizu; Norihisa Ishii; Yoshinori Umezawa; Joji Tada; Noriaki Kikuchi; Minoru Takata; Kenji Takamori; Mari Kishibe; Michi Tanaka; Yoshinori Miyamura; Shiro Ito; Yasushi Tomita
Journal:  Am J Hum Genet       Date:  2004-02-11       Impact factor: 11.025

8.  A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity.

Authors:  R K Tripathi; L B Giebel; K M Strunk; R A Spritz
Journal:  Gene Expr       Date:  1991-05

9.  A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.

Authors:  Saunie M Hutton; Richard A Spritz
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

10.  Identification and functional validation of a 5' upstream regulatory sequence in the human tyrosinase gene homologous to the locus control region of the mouse tyrosinase gene.

Authors:  Lucía Regales; Patricia Giraldo; Angel García-Díaz; Alfonso Lavado; Lluís Montoliu
Journal:  Pigment Cell Res       Date:  2003-12
View more
  40 in total

1.  Homozygosity mapping in albinism patients using a novel panel of 13 STR markers inside the nonsyndromic OCA genes: introducing 5 novel mutations.

Authors:  Faravareh Khordadpoor-Deilamani; Mohammad Taghi Akbari; Morteza Karimipoor; Gholam Reza Javadi
Journal:  J Hum Genet       Date:  2016-01-28       Impact factor: 3.172

2.  SLC24A5 mutations are associated with non-syndromic oculocutaneous albinism.

Authors:  Fanny Morice-Picard; Eulalie Lasseaux; Stéphane François; Delphine Simon; Caroline Rooryck; Eric Bieth; Estelle Colin; Dominique Bonneau; Hubert Journel; Sophie Walraedt; Bart P Leroy; Francoise Meire; Didier Lacombe; Benoit Arveiler
Journal:  J Invest Dermatol       Date:  2013-08-28       Impact factor: 8.551

3.  Clinical evaluation and molecular screening of a large consecutive series of albino patients.

Authors:  Lucia Mauri; Emanuela Manfredini; Alessandra Del Longo; Emanuela Veniani; Manuela Scarcello; Roberta Terrana; Adriano Egidio Radaelli; Donata Calò; Giuseppe Mingoia; Antonella Rossetti; Giovanni Marsico; Marco Mazza; Giovanni Pietro Gesu; Maria Cristina Patrosso; Silvana Penco; Elena Piozzi; Paola Primignani
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

4.  Microarray analysis of iris gene expression in mice with mutations influencing pigmentation.

Authors:  Colleen M Trantow; Tryphena L Cuffy; John H Fingert; Markus H Kuehn; Michael G Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

5.  Molecular and clinical characterization of albinism in a large cohort of Italian patients.

Authors:  Annagiusi Gargiulo; Francesco Testa; Settimio Rossi; Valentina Di Iorio; Simona Fecarotta; Teresa de Berardinis; Antonello Iovine; Adriano Magli; Sabrina Signorini; Elisa Fazzi; Maria Silvana Galantuomo; Maurizio Fossarello; Sandro Montefusco; Alfredo Ciccodicola; Alberto Neri; Claudio Macaluso; Francesca Simonelli; Enrico Maria Surace
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

6.  Rare germline variants in known melanoma susceptibility genes in familial melanoma.

Authors:  Alisa M Goldstein; Yanzi Xiao; Joshua Sampson; Bin Zhu; Melissa Rotunno; Hunter Bennett; Yixuan Wen; Kristine Jones; Aurelie Vogt; Laurie Burdette; Wen Luo; Bin Zhu; Meredith Yeager; Belynda Hicks; Jiali Han; Immaculata De Vivo; Stella Koutros; Gabriella Andreotti; Laura Beane-Freeman; Mark Purdue; Neal D Freedman; Stephen J Chanock; Margaret A Tucker; Xiaohong R Yang
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

7.  Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.

Authors:  Ighovie F Onojafe; David R Adams; Dimitre R Simeonov; Jun Zhang; Chi-Chao Chan; Isa M Bernardini; Yuri V Sergeev; Monika B Dolinska; Ramakrishna P Alur; Murray H Brilliant; William A Gahl; Brian P Brooks
Journal:  J Clin Invest       Date:  2011-10       Impact factor: 14.808

8.  Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.

Authors:  Monika B Dolinska; Nicole J Kus; S Katie Farney; Paul T Wingfield; Brian P Brooks; Yuri V Sergeev
Journal:  Pigment Cell Melanoma Res       Date:  2017-01       Impact factor: 4.693

9.  N-Ethylmaleimide-Sensitive Factor b (nsfb) Is Required for Normal Pigmentation of the Zebrafish Retinal Pigment Epithelium.

Authors:  Nicholas J Hanovice; Christina M S Daly; Jeffrey M Gross
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

Review 10.  Pigmentation and vision: Is GPR143 in control?

Authors:  Brian S McKay
Journal:  J Neurosci Res       Date:  2018-05-14       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.